Aktie - MEMY

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Current Price

0,606

Gebot

0,00

Fragen

0,00

Volumen

0,00 Tagesbereich 0,00

0,00 52-Wochen-Bereich 0,00

Handelsende

0,606

Handelsbeginn

Letzte Trade

Letzter Handelszeitpunkt

Durchschnittliches Volumen (3 Mio.)

Finanzvolumen

VWAP

Roche Purchases Shares in Tender Offer For Memory Pharmaceuticals Corp.

NUTLEY, N.J. and BASEL, Switzerland, Jan. 2 /PRNewswire-FirstCall/ -- Roche (SWX: ROG.VX; RO.S; OTCQX; RHHBY) today announced that its...

Memory Pharmaceuticals Initiates Biomarker Study of R3487/MEM 3454 in Schizophrenia

MONTVALE, N.J., Dec. 24 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. (NASDAQ:MEMY) today announced that it has dosed the first patient...

Memory Pharmaceuticals Reports Phase 1 Data for R4996/MEM 63908

MONTVALE, N.J., Dec. 19 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. (NASDAQ:MEMY) today announced positive results from its Phase 1...

Memory Pharmaceuticals Initiates Phase 2a Trial for MEM 1414 in Asthma

Study to Evaluate Proof-of-Concept for Company's Lead PDE4 Inhibitor MONTVALE, N.J., Dec. 18 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals...

Memory Pharmaceuticals Regains Compliance with NASDAQ Market Capitalization Requirement

MONTVALE, N.J., Dec. 16 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. (NASDAQ:MEMY) today announced that the NASDAQ Listing and Hearing...

Memory Pharmaceuticals Receives NASDAQ Decisions

- Company Granted Stay of Delisting by NASDAQ Review Council - MONTVALE, N.J., Dec. 3 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp...

Beacon Equity Issues Technical Trade Alerts on Market Movers: DIOD, MEMY, CSUN, CLWR, BARE, CHRS

DALLAS, Nov. 26 /PRNewswire/ -- BeaconEquity.com announces the availability of Trade Alerts on stocks making news today. Investors can view all...

Roche Signs Definitive Agreement to Acquire Memory Pharmaceuticals

NUTLEY, N.J. and MONTVALE, N.J., Nov. 25 /PRNewswire-FirstCall/ -- Roche and Memory Pharmaceuticals (NASDAQ:MEMY) today announced that the two...

Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophre

-Triggers $5 Million Payment from Roche- MONTVALE, N.J., Nov. 19 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. (NASDAQ:MEMY) today...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

MEMY - Frequently Asked Questions (FAQ)

What is the current share price?

The current share price of is US$ 0,606

What is the 1 year trading range for share price?

has traded in the range of US$ 0,00 to US$ 0,00 during the past year

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
SGLYSingularity Future Technology Ltd	US$ 1,6799 (143,43%)	30,76M
WINVWinVest Acquisition Corporation	US$ 25,00 (107,30%)	463
VVPRVivoPower International PLC	US$ 1,2899 (52,13%)	65,08M
RNAZTransCode Therapeutics Inc	US$ 1,12 (45,45%)	216,22M
GLTOGalecto Inc	US$ 6,00 (44,93%)	10,71M
YHCLQR House Inc	US$ 0,40 (-82,38%)	38,32M
KZIAKazia Therapeutics Ltd	US$ 0,9759 (-80,02%)	55,66k
DMNDamon Inc	US$ 0,0373 (-70,02%)	304,17M
TCBPTC BioPharm Holdings PLC	US$ 0,5046 (-67,23%)	5,9M
SOWGSow Good Inc	US$ 1,53 (-44,36%)	698,02k
DMNDamon Inc	US$ 0,0373 (-70,02%)	304,17M
NVDANVIDIA Corporation	US$ 117,70 (-0,70%)	264,42M
RNAZTransCode Therapeutics Inc	US$ 1,12 (45,45%)	216,22M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	US$ 9,03 (10,66%)	175,77M
HOLOMicroCloud Hologram Inc	US$ 1,00 (32,36%)	141,98M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Memory Pharmaceuticals Corp (MM) (MEMY)

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

MEMY Neueste Nachrichten

Roche Purchases Shares in Tender Offer For Memory Pharmaceuticals Corp.

Memory Pharmaceuticals Initiates Biomarker Study of R3487/MEM 3454 in Schizophrenia

Memory Pharmaceuticals Reports Phase 1 Data for R4996/MEM 63908

Memory Pharmaceuticals Initiates Phase 2a Trial for MEM 1414 in Asthma

Memory Pharmaceuticals Regains Compliance with NASDAQ Market Capitalization Requirement

Memory Pharmaceuticals Receives NASDAQ Decisions

Beacon Equity Issues Technical Trade Alerts on Market Movers: DIOD, MEMY, CSUN, CLWR, BARE, CHRS

Roche Signs Definitive Agreement to Acquire Memory Pharmaceuticals

Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophre

MEMY - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Memory Pharmaceuticals Corp (MM) (MEMY) Börsenkurse

Memory Pharmaceuticals Corp (MM) (MEMY)

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

MEMY Neueste Nachrichten

Roche Purchases Shares in Tender Offer For Memory Pharmaceuticals Corp.

Memory Pharmaceuticals Initiates Biomarker Study of R3487/MEM 3454 in Schizophrenia

Memory Pharmaceuticals Reports Phase 1 Data for R4996/MEM 63908

Memory Pharmaceuticals Initiates Phase 2a Trial for MEM 1414 in Asthma

Memory Pharmaceuticals Regains Compliance with NASDAQ Market Capitalization Requirement

Memory Pharmaceuticals Receives NASDAQ Decisions

Beacon Equity Issues Technical Trade Alerts on Market Movers: DIOD, MEMY, CSUN, CLWR, BARE, CHRS

Roche Signs Definitive Agreement to Acquire Memory Pharmaceuticals

Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophre

MEMY - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS